113 related articles for article (PubMed ID: 34126112)
1. A coordinated ruthenium-rifampicin complex reprogramming the colon carcinoma micro-environment mediated by modulation of p53/AkT/mTOR/VEGF pathway.
Zeng J; Zhao Y; Li K; Long D; Li W; Liang L
Toxicol Appl Pharmacol; 2021 Sep; 426():115618. PubMed ID: 34126112
[TBL] [Abstract][Full Text] [Related]
2. Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.
Roy S; Mondru AK; Chakraborty T; Das A; Dasgupta S
Toxicol Appl Pharmacol; 2022 Jan; 434():115822. PubMed ID: 34896434
[TBL] [Abstract][Full Text] [Related]
3. Construing the Biochemical and Molecular Mechanism Underlying the
Wang Y; Bian L; Chakraborty T; Ghosh T; Chanda P; Roy S
Int J Biol Sci; 2019; 15(5):1052-1071. PubMed ID: 31182925
[TBL] [Abstract][Full Text] [Related]
4. Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Jin G; Zhao Z; Chakraborty T; Mandal A; Roy A; Roy S; Guo Z
Oxid Med Cell Longev; 2020; 2020():7690845. PubMed ID: 32566099
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer.
Roy S; Das R; Ghosh B; Chakraborty T
Mol Carcinog; 2018 Jun; 57(6):700-721. PubMed ID: 29442390
[TBL] [Abstract][Full Text] [Related]
7. Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.
Ponnurangam S; Standing D; Rangarajan P; Subramaniam D
Mol Cancer Ther; 2013 May; 12(5):598-609. PubMed ID: 23427297
[TBL] [Abstract][Full Text] [Related]
8. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
9. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
You S; Li W; Guan Y
Mol Med Rep; 2018 Mar; 17(3):4203-4212. PubMed ID: 29344654
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.
Savic M; Arsenijevic A; Milovanovic J; Stojanovic B; Stankovic V; Rilak Simovic A; Lazic D; Arsenijevic N; Milovanovic M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066568
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of petasin on human colon carcinoma cells mediated by inactivation of Akt/mTOR pathway.
Lyu X; Song AL; Bai YL; Xu XD; He DQ; Zhang YC
Chin Med J (Engl); 2019 May; 132(9):1071-1078. PubMed ID: 30896562
[TBL] [Abstract][Full Text] [Related]
12. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markers.
Kabel AM; Ashour AM; Ali DA; Arab HH
Int Immunopharmacol; 2021 Sep; 98():107830. PubMed ID: 34118646
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis-induced effects of extract from Artemisia annua Linné by modulating PTEN/p53/PDK1/Akt/ signal pathways through PTEN/p53-independent manner in HCT116 colon cancer cells.
Kim EJ; Kim GT; Kim BM; Lim EG; Kim SY; Kim YM
BMC Complement Altern Med; 2017 Apr; 17(1):236. PubMed ID: 28454566
[TBL] [Abstract][Full Text] [Related]
15. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
[TBL] [Abstract][Full Text] [Related]
16. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
[TBL] [Abstract][Full Text] [Related]
17. Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation.
You P; Wu H; Deng M; Peng J; Li F; Yang Y
Biomed Pharmacother; 2018 Feb; 98():619-625. PubMed ID: 29289836
[TBL] [Abstract][Full Text] [Related]
18. Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.
Kapral M; Wawszczyk J; Jesse K; Paul-Samojedny M; Kuśmierz D; Węglarz L
Molecules; 2017 Oct; 22(10):. PubMed ID: 28972559
[No Abstract] [Full Text] [Related]
19. Piclamilast mitigates 1,2-dimethylhydrazine induced colon cancer in rats through modulation of Ras/PI3K/Akt/mTOR and NF-κβ signaling.
Abdel-Wahab BA; Alqhtani H; Walbi IA; Albarqi HA; Aljadaan AM; Khateeb MM; Hassanein EHM
Chem Biol Interact; 2021 Dec; 350():109686. PubMed ID: 34627785
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
